InVivo

NVIV NASDAQ
0.7700
+0.0400
+5.48%
交易中 14:00 06/24 EDT
开盘
0.7233
昨收
0.7300
最高
0.7700
最低
0.7022
成交量
5,719
成交均量(3M)
7.35万
52周最高
2.750
52周最低
0.6520
换手率
0.06%
市值
716.97万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供InVivo NVIV股票价格,InVivo股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.
展开 >

最近浏览

名称
价格
涨跌幅